» Articles » PMID: 35466399

Vitamin D Concentrations and Breast Cancer Incidence Among Black/African American and Non-Black Hispanic/Latina Women

Overview
Journal Cancer
Publisher Wiley
Specialty Oncology
Date 2022 Apr 25
PMID 35466399
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Vitamin D may protect against breast cancer. Although Black/African American women and Hispanic/Latina women have lower circulating vitamin D levels than non-Hispanic White women, few studies have examined the association between vitamin D and breast cancer within these racial/ethnic groups.

Methods: The vitamin D-breast cancer association was evaluated using a case-cohort sample of self-identified Black/African American and non-Black Hispanic/Latina women participating in the US-wide Sister Study cohort. Circulating 25-hydroxyvitamin D (25(OH)D) and 24,25-dihydroxyvitamin D (24,25(OH)2D) were measured using liquid chromatography-tandem mass spectrometry in blood samples collected at the baseline from 415 women (290 Black/African American women and 125 non-Black Hispanic/Latina women) who developed breast cancer. These were compared to concentrations in 1545 women (1084 Black/African American women and 461 Hispanic/Latina women) randomly selected from the cohort. Multivariable-adjusted Cox regression was used to estimate hazard ratios (HRs) and 95% confidence intervals (CIs).

Results: Over a mean follow-up of 9.2 years, women with circulating 25(OH)D concentrations above the clinical cut point for deficiency (20.0 ng/mL) had lower breast cancer rates than women with concentrations ≤ 20 ng/mL (HR, 0.79; 95% CI, 0.61-1.02). The inverse association was strongest among Hispanic/Latina women (HR, 0.52; 95% CI, 0.29-0.93), with a weaker association observed among Black/African American women (HR, 0.89; 95% CI, 0.68-1.18; P for heterogeneity = 0.13). There were no clear differences by menopausal status, follow-up time, estrogen receptor status, or invasiveness. Neither 24,25(OH) D nor the 24,25(OH) D to 25(OH)D ratio were independently associated with breast cancer risk.

Conclusions: This prospective study supports the hypothesis that vitamin D may be protective against breast cancer incidence in women, including non-Black Hispanic/Latina and Black/African American women.

Lay Summary: Vitamin D may protect against breast cancer. Although women of color have lower average vitamin D levels than non-Hispanic White women, few studies have considered the role of race/ethnicity. In a sample of self-identified Black/African American and Hispanic/Latina women, we observed that vitamin D concentrations measured in blood were inversely associated with breast cancer, particularly among Latinas. These findings indicate that vitamin D may protect women against breast cancer, including those in racial/ethnic groups with low average circulating levels.

Citing Articles

The Impact of Vitamin D and Its Dietary Supplementation in Breast Cancer Prevention: An Integrative Review.

Torres A, Cameselle C, Otero P, Simal-Gandara J Nutrients. 2024; 16(5).

PMID: 38474702 PMC: 10934904. DOI: 10.3390/nu16050573.


Association of Fibroids, Endometriosis, and Gynecologic Surgeries with Breast Cancer Incidence and Hormone Receptor Subtypes.

Zeldin J, Sandler D, Ogunsina K, OBrien K Cancer Epidemiol Biomarkers Prev. 2024; 33(4):576-585.

PMID: 38260971 PMC: 10990796. DOI: 10.1158/1055-9965.EPI-23-1014.

References
1.
Bertrand K, Giovannucci E, Liu Y, Malspeis S, Eliassen A, Wu K . Determinants of plasma 25-hydroxyvitamin D and development of prediction models in three US cohorts. Br J Nutr. 2012; 108(10):1889-96. PMC: 3346859. DOI: 10.1017/S0007114511007409. View

2.
OBrien K, Sandler D, House M, Taylor J, Weinberg C . The Association of a Breast Cancer Diagnosis With Serum 25-Hydroxyvitamin D Concentration Over Time. Am J Epidemiol. 2019; 188(4):637-645. PMC: 6454838. DOI: 10.1093/aje/kwy285. View

3.
OBrien K, Cole S, Tse C, Perou C, Carey L, Foulkes W . Intrinsic breast tumor subtypes, race, and long-term survival in the Carolina Breast Cancer Study. Clin Cancer Res. 2010; 16(24):6100-10. PMC: 3029098. DOI: 10.1158/1078-0432.CCR-10-1533. View

4.
Wu Y, Sarkissyan M, Clayton S, Chlebowski R, Vadgama J . Association of Vitamin D3 Level with Breast Cancer Risk and Prognosis in African-American and Hispanic Women. Cancers (Basel). 2017; 9(10). PMC: 5664083. DOI: 10.3390/cancers9100144. View

5.
Kulathinal S, Karvanen J, Saarela O, Kuulasmaa K . Case-cohort design in practice - experiences from the MORGAM Project. Epidemiol Perspect Innov. 2007; 4:15. PMC: 2216006. DOI: 10.1186/1742-5573-4-15. View